BAUDETTE, Minn., Feb. 20, 2018 /PRNewswire/ -- ANI
Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the
Company plans to release its fourth quarter and full year 2017
financial results and 2018 guidance on Tuesday, February 27, 2018, before the opening of
the U.S. financial markets. The earnings press release will be
accessible through the Investor Relations section of the Company's
website, www.anipharmaceuticals.com.
Arthur S. Przybyl, President and
Chief Executive Officer, and Stephen P.
Carey, Vice President, Finance, and Chief Financial Officer,
also plan to host a conference call to review those results
starting at 10:30am Eastern Time on
Tuesday, February 27, 2018. The call will be open to the
public and can be accessed through a conference line by dialing
(866) 776-8875. The conference ID is 9773589.
A recording of the conference call will be available within two
hours of the completion of the call and will remain accessible for
a period of seven days following the call. To access the replay,
dial (800) 585-8367. The access code for the replay is 9773589.
About ANI
ANI Pharmaceuticals, Inc. (the "Company" or "ANI") is an
integrated specialty pharmaceutical company focused on delivering
value to our customers by developing, manufacturing, and marketing
high quality branded and generic prescription pharmaceuticals. The
Company's targeted areas of product development currently include
controlled substances, oncolytics (anti-cancers), hormones and
steroids, and complex formulations involving extended release and
combination products. For more information, please visit our
website www.anipharmaceuticals.com.
For more information about ANI, please contact:
Investor Relations
IR@anipharmaceuticals.com
View original
content:http://www.prnewswire.com/news-releases/ani-pharmaceuticals-schedules-conference-call-to-discuss-fourth-quarter-and-full-year-2017-financial-results-and-2018-guidance-300600292.html
SOURCE ANI Pharmaceuticals, Inc.